IEX vs KAI: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
IEX is the larger of the two ($16.99B market cap): the incumbent the market prices for continued execution (24.35x forward earnings, beta 0.97). KAI is the smaller challenger ($3.95B), priced similarly on forward earnings (24.73x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
IEX vs KAI: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | IEX | KAI | What it tells you |
|---|---|---|---|
| Market cap | $16.99B | $3.95B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 24.35 | 24.73 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 33.11 | 35.98 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.97 | 1.18 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 85% of range | 82% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 4.23 | 3.82 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how IEX and KAI affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. IEX and KAI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined IEX and KAI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does IDEX Corporation (IEX) do?
IDEX Corporation is an applied solutions company that designs and manufactures highly engineered pumps, flow meters, valves, fluidic systems, and other components used to move and measure fluids. It operates across three reporting segments: Health & Science Technologies (precision fluidics, optics, and sealing for life science, analytical instruments, and semiconductors), Fluid & Metering Technologies (industrial pumps, metering, and water and wastewater equipment), and Fire & Safety/Diversified Products (rescue tools, fire suppression components, and dispensing equipment). Its products are typically small pieces of larger customer systems where reliability matters more than price, which supports pricing power and recurring aftermarket demand.
What does Kadant Inc. (KAI) do?
Kadant Inc. builds the equipment that keeps industrial process lines running, organised into three reportable segments. Flow Control sells rotary sealing devices, steam systems, doctor blades, cleaning and filtration gear into packaging, paper, tissue, food, energy and defense plants, and produced ~$100M of revenue in the second quarter of 2026. Industrial Processing, the largest segment at ~$144M, supplies stock-preparation and recycling equipment for paper and paperboard plus stranders and debarkers for wood processing. Material Handling, at ~$69M, covers vibratory conveying, baling and related systems. The common thread is that each machine wears out consumable components, so Kadant sells replacements for decades after the original sale. Parts and consumables were ~68% of second-quarter revenue and ~72% of bookings.
IEX vs KAI: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- IEX drivers: Health & Science Technologies momentum; Disciplined bolt-on acquisitions.
- KAI drivers: The aftermarket annuity; Serial acquisition of niche installed bases.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: IDEX is exposed to broad industrial cyclicality, and softness in chemical and certain short-cycle end markets has periodically offset strength elsewhere. For KAI, capital-order timing is the single largest swing factor, and organic bookings already turned slightly negative in the second quarter.
IEX or KAI: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick IEX if you believe its drivers more; KAI if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the IEX and KAI guides.
IEX vs KAI: the full fundamentals
IEX. As of July 2026 IEX traded around $224 with a market cap near $16.5 billion and a trailing P/E in the low 30s, a premium typical of high-quality, acquisitive industrials. The valuation reflects consistent margins, record orders, and raised guidance, but it also leaves limited cushion if end markets weaken. The dividend yield sits near 1.3%, with the company having raised its payout for more than 15 consecutive years.
KAI. At roughly ~$334 a share the market is paying about ~36 times trailing earnings and ~27 times the midpoint of guided 2026 adjusted EPS, a premium to the average industrial machinery name that rests on the recurring-parts mix. The bridge from guided GAAP EPS to adjusted EPS is ~$2.65 per share, so which number an investor anchors to changes the multiple by roughly a third. Free cash flow of ~$43M in the quarter and a covenant leverage ratio of ~1.72 leave capacity for further deals.
Headline figures (approximate, July 2026): IEX shows revenue (ttm) ~$3.4B, q1 2026 net sales ~$887M (+9% YoY), q1 2026 orders ~$988M (record, +13%), adjusted ebitda margin ~26%; KAI shows revenue (ttm) ~$1.15B, diluted eps (ttm) / p/e ~$9.30 / ~36x, 2026 guidance revenue ~$1.19B to ~$1.21B, adjusted EPS ~$12.43 to ~$12.68, adjusted ebitda margin (q2 2026) ~21.8%.
The bottom line: IEX vs KAI
IEX and KAI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined IEX and KAI exposure against your real portfolio. It is not an investment adviser.
Wondering how IEX or KAI fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in IDEX Corporation with AI
Connect the broker you already use and ask Walnut's AI how IEX fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between IEX and KAI?
+
IDEX Corporation is an applied solutions company that designs and manufactures highly engineered pumps, flow meters, valves, fluidic systems, and other components used to move and measure fluids. Kadant Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is IEX or KAI the better stock?
+
Neither is universally better. IEX is the larger incumbent; KAI is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, IEX or KAI?
+
On forward P/E (as of August 2026), IEX trades at 24.35x and KAI at 24.73x, so IEX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both IEX and KAI?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of IEX vs KAI?
+
IEX: IDEX is exposed to broad industrial cyclicality, and softness in chemical and certain short-cycle end markets has periodically offset strength elsewhere. Its acquisition-driven model carries integration and capital-allocation risk, and paying too much for deals or misjudging end markets could dilute returns. The stock trades at a premium industrial multiple (trailing P/E in the low 30s), so any growth or margin disappointment could compress the valuation. Currency swings, supply chain costs, and demand tied to customer capital spending in life science and semiconductors add variability. A slowdown in global manufacturing or infrastructure investment would pressure organic growth. KAI: Capital-order timing is the single largest swing factor, and organic bookings already turned slightly negative in the second quarter. Gross margin fell ~210 basis points to ~43.8%, partly because acquired revenue carries a lower margin profile, so the M&A that produces the growth also dilutes the quality of it. Debt climbed from roughly ~$374M at fiscal year end to about ~$511M to fund Kadant Profil, and second-quarter interest expense rose ~59% year over year, which raises the cost of a deal that disappoints. The gap between guided GAAP EPS of ~$9.78 to ~$10.03 and adjusted EPS of ~$12.43 to ~$12.68 is ~$2.65 per share of acquisition-related costs and intangible amortisation, a recurring feature for a serial acquirer rather than a one-time adjustment. With ~11.8M shares outstanding and daily volume often under ~100,000 shares, the stock is thinly traded, and paper, packaging and European industrial demand remain genuinely cyclical.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell IEX or KAI; figures are approximate and dated (as of August 2026). Verify current data before investing.